Pulmonary vein isolation balloon catheter

ABSTRACT

The instant disclosure relates to electrophysiology catheters for tissue ablation within a cardiac muscle. In particular, the instant disclosure relates to an electrophysiology ablation balloon catheter with an electrode coil that is wrapped around at least a portion of the balloon and delivers ablation energy at a desired portion of tissue.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application No.62/443,235, filed 6 Jan. 2017, the entire disclosure of which is herebyincorporated by reference as though fully set forth herein.

BACKGROUND a. Field

The instant disclosure relates to catheters, in particular catheters forconducting ablation therapy within a heart or other tissue. In oneembodiment, the instant disclosure relates to a catheter for treatingcardiac arrhythmias by ablating pulmonary venous tissue or in thevicinity thereto.

b. Background Art

The human heart routinely experiences electrical currents traversing itsmany surfaces and ventricles, including the endocardial chamber. Justprior to each heart contraction, the heart depolarizes and repolarizes,as electrical currents spread across the heart and throughout the body.In healthy hearts, the surfaces and ventricles of the heart willexperience an orderly progression of depolarization waves. In unhealthyhearts, such as those experiencing atrial arrhythmia, including forexample, ectopic atrial tachycardia, atrial fibrillation, and atrialflutter, the progression of the depolarization wave becomes chaotic.Arrhythmias may persist as a result of scar tissue or other obstacles torapid and uniform depolarization. These obstacles may causedepolarization waves to electrically circulate through some parts of theheart more than once. Atrial arrhythmia can create a variety ofdangerous conditions, including irregular heart rates, loss ofsynchronous atrioventricular contractions, and blood flow stasis. All ofthese conditions have been associated with a variety of ailments, anddeath.

Catheters are used in a variety of diagnostic and/or therapeutic medicalprocedures to correct atrial arrhythmia conditions, including forexample, ectopic atrial tachycardia, atrial fibrillation, and atrialflutter.

During atrial fibrillation therapy, a catheter may be manipulatedthrough a patient's vasculature to, for example, a patient's heart, andmay carry one or more electrodes which may be used for mapping,ablation, diagnosis, or other treatments. To alleviate symptomsincluding atrial arrhythmia, an ablation catheter imparts ablativeenergy to cardiac tissue to create a lesion in the cardiac tissue. Thelesioned tissue is less capable of conducting electrical signals,thereby disrupting undesirable electrical pathways and limiting orpreventing stray electrical signals that lead to arrhythmias. Theablation catheter may utilize ablative energy including, for example,radio frequency (RF), cryoablation, laser, chemical, irreversibleelectroporation, and high-intensity focused ultrasound.

The foregoing discussion is intended only to illustrate the presentfield and should not be taken as a disavowal of claim scope.

BRIEF SUMMARY

The instant disclosure relates to electrophysiology catheters for tissueablation within the heart, or other tissue. In particular, the instantdisclosure relates to balloon catheters with flexible electrode coilsextending across an outer surface of the balloon and focusing ablativeenergy at target tissue in contact with the flexible electrode coils.

Aspects of the present disclosure are directed to an ablation ballooncatheter apparatus. The ablation balloon catheter apparatus includes acatheter shaft with proximal and distal ends, a balloon, and anelectrode coil. The balloon includes proximal and distal ends, theproximal end of the balloon coupled to a distal end of the cathetershaft. The electrode coil extends around at least a portion of theballoon, the electrode coil is configured to transfer energy between theelectrode coil and tissue in contact with the electrode coil. In morespecific embodiments, the balloon engages a pulmonary vein of a cardiacmuscle along a length and circumference of the balloon, thereby placingthe electrode coil into contact with the circumferential portion of thepulmonary vein. The electrode coil delivers a tissue ablation therapy tothe circumferential portion of the pulmonary vein in contact with theelectrode coil.

Some embodiments of the present disclosure are directed to a system fortreating atrial fibrillation. The system may include an introducer, aballoon delivery catheter, a balloon, and an electrode coil. Theintroducer includes a lumen extending through a length of theintroducer, and the balloon delivery catheter extends through the lumenof the introducer. The balloon is coupled to a distal end of the balloondelivery catheter. The electrode coil extends around at least a portionof the balloon, engages with a tissue wall of a pulmonary vein, anddelivers an ablation therapy along the tissue wall of the pulmonary veinengaged by the electrode coil. In more specific embodiments, the balloonengages with a length and circumference of the pulmonary vein adjacentto the tissue wall engaged with the electrode coil, and insulates thelength and circumference of the pulmonary vein engaged by the balloonfrom the ablation therapy.

Various other embodiments of the present disclosure are directed to aballoon catheter for pulmonary vein isolation. The balloon catheter mayinclude a balloon, a steerable balloon delivery catheter shaft to deploythe balloon into a pulmonary vein, and a tissue ablation means. Theballoon is coupled to a distal end of the steerable balloon deliverycatheter shaft, deploys from an undeployed configuration, and engages atissue wall of the pulmonary vein. The tissue ablation means extendsaround at least a portion of the balloon, and delivers an ablationtherapy to the tissue wall of the pulmonary vein in contact with thetissue ablation means. In some more specific embodiments, the tissueablation means is positioned near a distal portion of the balloon, andengages and conducts an ablation therapy on an ostial circumference ofthe pulmonary vein. The proximal portion of the balloon insulates ablood pool and the pulmonary vein tissue in contact with a proximalportion of the balloon.

The foregoing and other aspects, features, details, utilities, andadvantages of the present disclosure will be apparent from reading thefollowing description and claims, and from reviewing the accompanyingdrawings.

BRIEF DESCRIPTION OF THE DRAWINGS

Various example embodiments may be more completely understood inconsideration of the following detailed description in connection withthe accompanying drawings.

FIG. 1 is a schematic and diagrammatic view of a catheter system forperforming a therapeutic medical procedure, consistent with variousaspects of the present disclosure.

FIG. 2 is a cross-sectional front-view of a left atrium with a collapsedballoon catheter extending out of an introducer and into the leftatrium, consistent with various aspects of the present disclosure.

FIG. 3 is a cross-sectional front-view of a left atrium with an expandedballoon catheter locating a pulmonary vein, consistent with variousaspects of the present disclosure.

FIG. 4 is a cross-sectional front-view of a pulmonary vein with anexpanded balloon catheter positioned in circumferential contacttherewith, consistent with various aspects of the present disclosure.

FIG. 5 is an isometric side view of a deployed balloon catheter,consistent with various aspects of the present disclosure.

FIG. 6 is an isometric side view of a deployed balloon catheter and anelectrophysiology loop catheter extending through a central lumen of theballoon catheter, consistent with various aspects of the presentdisclosure.

FIG. 7 is an isometric side view of a deployed balloon catheter,consistent with various aspects of the present disclosure.

FIG. 8A is an isometric side view of a deployed balloon catheter,consistent with various aspects of the present disclosure.

FIG. 8B is a profile view of the deployed balloon catheter in FIG. 8A,consistent with various aspects of the present disclosure.

FIG. 8C is a cross-sectional side view of various electrode coilprofiles, consistent with various aspects of the present disclosure.

FIG. 9 is a profile view of an undeployed balloon catheter, consistentwith various aspects of the present disclosure.

While various embodiments discussed herein are amenable to modificationsand alternative forms, aspects thereof have been shown by way of examplein the drawings and will be described in detail. It should beunderstood, however, that the intention is not to limit the scope to theparticular embodiments described. On the contrary, the intention is tocover all modifications, equivalents, and alternatives falling withinthe scope of the disclosure including aspects defined in the claims. Inaddition, the term “example” as used throughout this application is onlyby way of illustration, and not limitation.

DETAILED DESCRIPTION OF EMBODIMENTS

The instant disclosure relates to electrophysiology catheters for tissueablation within the heart, other organs, and tissue within the body. Inparticular, the instant disclosure relates to a balloon catheter withflexible electrode coils extending across an outer surface of theballoon for focusing ablative energy at target tissue. In somecardiac-related applications for treating atrial fibrillation, forexample, pulmonary venous tissue is ablated to alleviate symptoms and/orcure the condition entirely. Various embodiments of the presentdisclosure are described below with specific reference to the figures.These embodiments are directed toward atrial fibrillation treatment, butmay be readily applied to various conditions, and other organs andtissue within a human body.

Ablation therapies may be delivered by making a number of individualablations in a controlled fashion in order to form a lesion line. In thecase of atrial fibrillation, such lesion lines are often formedaround/between the pulmonary veins in the left atrium of the heart,which have been associated with the introduction of erratic electricsignals into the heart. Various embodiments of the present disclosureare directed to minimizing applications of energy to the pulmonaryveins. Existing designs include ablation balloons with energy applyingfeatures within the balloon itself; however, such designs suffer from alack of ability to focus ablation energy at a target circumference andlength of the pulmonary vein during therapy delivery, resulting inenergy loss to the blood pool and unintentional ablation of non-targettissue. Moreover, the resulting energy loss may reduce the efficacy oftarget tissue ablation, cause inconsistent lesion lines, and incompleteelectrical signal blockage. In some cases, unintentional ablation ofnon-target tissue may cause pulmonary vein stenosis, phrenic nerveinjury, and esophageal damage.

Radio frequency (RF) point-by-point catheter ablation is one commonpulmonary vein isolation technique; however, RF point-by-point catheterablation is time consuming due to the numerous individual ablations thatare required to form the desired linear lesions, and the precisepositioning needed. In an effort to simplify and shorten proceduretimes, circular or loop-type catheters with multiple electrodes formapping and ablation (e.g., Medtronic's PVAC or Biosense Webster'snMARC) simultaneously conduct each of the individual ablations around apulmonary vein. Such loop-type catheters mitigate the repetitivepositioning concerns of RF point-by-point catheter ablation. However,loop-type catheters often suffer from less than optimal tissue contact.Specifically, the electrodes in the loop-type catheter are not able toconform to a varying geometry of the left atrium and the pulmonary veins(PV). As a result, loop-type catheters often suffer from incompleteelectrical signal blockage as one or more of the electrodes lack thenecessary tissue contact (during a therapy) to properly ablate thecontacted tissue. Aspects of the present disclosure are directed toballoon catheters that facilitate proper electrode-tissue contact byextending a loop-type catheter (also referred to as an electrode coil)into contact with the target tissue (e.g., PV ostia), and creating acontiguous transmural circumferential lesion.

Balloon based ablation has been used for various therapeuticapplications in the medical field, including pulmonary vein isolation(PVI) procedures. Embodiments disclosed herein may be readily adapted toutilize various energy sources to deliver the ablation therapy includingradiofrequency, ultrasound, laser, cryogenic fluid and others. Aspectsof U.S. Pat. Nos. 6,952,615, 7,112,198, 8,231,617, and 8,647,339,disclose various high frequency RF thermal balloon catheters whichuniformly ablate the tissue in contact with the balloon, each of whichare hereby incorporated by reference as though fully set forth herein.In various embodiments consistent with the present disclosure, lesionsmay be created through capacitive type heating where transmitted RFenergy heats the tissue in contact with the balloon; however, largeamounts of energy are lost through non-tissue contacting areas of theballoon, such as portions of the balloon in contact with a blood poolwhich may act as a highly efficient heat sink. Various embodiments ofthe present disclosure improve energy delivery efficiency by placing RFelectrodes around an outer circumference of a balloon and into directcontact with targeted PV tissue (e.g., antrum and/or ostia). As aresult, RF energy is directly delivered to the target pulmonary vein,greatly limiting the energy absorbed by the blood pool or other tissue.In further embodiments, the balloon and/or the fluid inside the balloonmay be thermally insulative. As the blood pool is insulated from the RFenergy, the incidence for blood coagulation in the stagnant blood pooladjacent the balloon may be greatly reduced. Blood coagulation may bedeadly for patients, where the clots are transported through thecirculatory system once normal cardiovascular circulation is restored.

Referring now to the drawings wherein like reference numerals are usedto identify similar components in the various views, FIG. 1 is aschematic and diagrammatic view of a catheter ablation system 100 forperforming a tissue ablation procedure. In one embodiment, tissue 120comprises cardiac tissue within a human body 140. It should beunderstood, however, that the system may find applications in connectionwith a variety of tissue within a human body, and therefore, the presentdisclosure is not meant to be limited to the use of the system inconnection with only cardiac tissue.

Catheter ablation system 100 may include a catheter 160 and an ablationsubsystem 180 for controlling an ablation therapy conducted by a balloon130 at a distal end 128 of the catheter 160. The balloon 130 including aflexible electrode coil extending around an outer surface of theballoon. The ablation subsystem 180 can control the application of,and/or generation of, ablative energy including, for example, radiofrequency (RF), cryoablation, laser, irreversible electroporation,chemical, and high-intensity focused ultrasound.

In the example embodiment of FIG. 1, catheter 160 is provided forexamination, diagnosis, and/or treatment of internal body tissue such ascardiac tissue 120. The catheter may include a cable connector orinterface 121, a handle 122, a shaft 124 having a proximal end 126 and adistal end 128 (as used herein, “proximal” refers to a direction towardthe end of the catheter 160 near the handle 122, and “distal” refers toa direction away from the handle 122), and an ablation balloon 130coupled to the distal end of the catheter shaft 124.

In one example embodiment, balloon 130 is manipulated throughvasculature of a patient 140 using handle 122 to steer one or moreportions of shaft 124, and position the ablation balloon at a desiredlocation within a heart. In various embodiments, ablation elements aredistributed across a flexible electrode which extends around the outersurface of the balloon. The ablation elements may be RF coils, IREablation electrodes, high intensity focused ultrasound ablationelements, etc. When the ablation elements are operated by ablationsubsystem 180, the tissue 120 in contact with the balloon 130 isablated.

In various specific embodiments of the present disclosure, catheter 160may include electrophysiology electrodes and one or more positioningsensors (e.g., impedance-based or magnetic positioning sensors) at adistal end 128 of catheter shaft 124. The electrophysiology electrodesacquire electrophysiology data relating to cardiac tissue 120, while thepositioning sensor(s) generate positioning data indicative of the threedimensional position of balloon 130. In further embodiments, thecatheter 160 may further include other conventional catheter componentssuch as, for example and without limitation, steering wires andactuators, irrigation lumens and ports, pressure sensors, contactsensors, temperature sensors, additional diagnostic electrodes, andcorresponding conductors, leads, or traces.

Connector 121 provides mechanical and electrical connection(s) for oneor more cables 132 extending, for example, from ablation subsystem 180to ablation balloon 130 mounted at a distal end 128 of catheter shaft124. In other embodiments, the connector may also provide mechanical,electrical, and/or fluid connections for cables extending from othercomponents in catheter system 100, such as, for example, a fluid source(when the catheter 160 comprises an irrigated catheter) andcontact/pressure sensing circuitry. The connector 121 is conventional inthe art and is disposed at a proximal end 126 of the catheter 160.

Handle 122 provides a location for a user to hold catheter 160 and mayfurther provide steering or guidance for the shaft 124 within the body140. For example, the handle 122 may include means to manipulate one ormore steering wires extending through the catheter 160 to a distal end128 of the shaft 124, thereby facilitating steering of the shaft. Thehandle 122 is conventional in the art and it will be understood that theconstruction of the handle may vary. In other embodiments, control ofthe catheter 160 may be automated by robotically driving or controllingthe catheter shaft 124, or driving and controlling the catheter shaft124 using a magnetic-based guidance system.

Catheter shaft 124 is an elongated, tubular, and flexible memberconfigured for movement within a patient's body 140. The shaft supportsa balloon 130 at a distal end 128 of catheter 160. The shaft 124 mayalso permit transport, delivery and/or removal of fluids (includingirrigation fluids, cryogenic ablation fluids, and body fluids),medicines, and/or surgical tools or instruments. The shaft 124, whichmay be made from conventional materials used for catheters, such aspolyurethane, defines one or more lumens configured to house and/ortransport electrical conductors, fluids, and/or surgical tools. Thecatheter may be introduced into a blood vessel or other structure withinthe body 140 through a conventional introducer.

In one example cardiac ablation therapy, to correct for atrialarrhythmia, the introducer is introduced through a peripheral vein(typically a femoral vein) and advanced into right atrium. In what isreferred to as a transeptal approach, an incision in the fossa ovalis ismade, and the introducer extends through the incision in the fossaovalis. The ablation catheter 160 may then be extended through a lumenof the introducer into the left atrium. Catheter shaft 124 of ablationcatheter 160 may then be steered or guided through the left atrium toposition balloon 130 into a desired location within the left atrium suchas a pulmonary vein.

To achieve effective and efficient ablation of target myocardial tissuein contact with balloon 130, one or more electrode coilscircumnavigating an outer surface of the balloon 130 are sandwichedbetween the balloon and tissue. Due to the direct contact between theelectrode coils and tissue, energy transfer is focused in a way thatlimits energy transfer to non-target tissue. Accordingly, aspects of thepresent disclosure focus energy transfer to target tissue by couplingelectrode coils with RF electrodes to an external surface of the balloonwhere target tissue will interface. As the RF electrodes are in directthermal contact with the target tissue, and insulated from thenon-target tissue and blood pool by the balloon, the RF energy emittedis largely absorbed by the target tissue, thereby increasing the overallefficiency of the system and reducing the risk of unintentional tissueablation. In various embodiments, the balloon walls, and/or fluid withinthe walls may have a dielectric effect to further prevent unintentionalRF energy distribution. Aspects of the present disclosure are directedto RF energy tissue ablation, and may be readily adapted for directcurrent electroporation ablation (also referred to as irreversibleelectroporation (IRE)).

FIG. 2 is a cross-sectional front-view of a portion of cardiac muscle210 with an balloon catheter 231 locating a pulmonary vein (e.g., 214,216, 218, and 220) for performing an ablation therapy. As shown in FIG.2, the cardiac muscle 210 includes two upper chambers called the leftatrium 212L and right atrium 212R, and two lower chambers called theleft ventricle and right ventricle (partially visible).

Aspects of the present disclosure are directed to ablation therapies inwhich tissue in pulmonary veins 214, 216, 218, and 220, which formconductive pathways for electrical signals traveling through the tissue,is destroyed in order to electrically isolate sources of unwantedelectrical impulses (e.g., arrhythmiatic foci) located in the pulmonaryveins. By either destroying arrhythmiatic foci, or electricallyisolating the arrhythmiatic foci from the left atrium 212L, the cause ofatrial fibrillation symptoms can be reduced or eliminated entirely.

As shown in FIG. 2, an ablation balloon catheter 231 may be introducedinto the left atrium 212L by an introducer 230. A distal portion ofcatheter shaft 234 may guide the ablation balloon 236, once introducedinto the left atrium 212L by the introducer 230. Optionally, theablation balloon catheter 231 may include mapping electrodes at proximaland distal ends of the ablation balloon 236. In operation, introducer230 has its distal end positioned within left atrium 212L. As shown inFIG. 2, a transeptal approach has been utilized in which introducer 230is introduced through a peripheral vein (typically a femoral vein),advanced through right atrium 212R into left atrium 212L via atranseptal puncture, and anchored to the wall 226 of the fossa ovalis224.

Once introducer 230 is in position within left atrium 212L, steerableablation balloon catheter 231 is advanced out a distal end of theintroducer 230 and toward one of the pulmonary veins (e.g., 214, 216,218, and 220). In FIG. 2, the target pulmonary vein is right superiorpulmonary vein 214. A distal portion of the catheter shaft 234 ismanipulated until the distal tip of the ablation balloon catheter isdirected toward the target pulmonary vein 214.

Where the therapy is directed toward antrum of a pulmonary vein, balloon236 is deployed, and then extended into contact with the antrum.Alternatively, where the therapy is directed toward a pulmonary veinostium, the balloon 236 is extended into the pulmonary vein. Carriednear a distal end of balloon catheter 231, balloon 236 remains in acollapsed condition so that it may enter into the target pulmonary vein214. Once in position within the ostium, the balloon 236 is deployed, sothat it engages and secures the ablation balloon catheter 231 within thetarget pulmonary vein 214. In some applications, it may be desirable toocclude the flow of blood from the pulmonary vein into the left atrium.To confirm proper occlusion of the pulmonary vein, fluoroscopic die maybe injected into the blood pool within the pulmonary vein (which isvisible via fluoroscopic imaging)—where the fluoroscopic die stagnateswithin the pulmonary vein, the ablation balloon is effectively occludingthe pulmonary vein. Once proper position of the ablation balloon isverified, ablation therapy may be initiated.

In FIG. 2, an electrode coil 237 extends around at least a portion ofthe circumference of balloon 236. When the balloon is radially expanded,the electrode coil 237 is also extended into a deployed configurationabout the balloon, and sandwiched between the PV tissue and the balloon236. The electrode coil 237 includes ablation means, such as RF coilsdistributed along the coil, and may also include diagnostic/mappingelectrodes, and thermocouples.

To ablate tissue, once deployed, the electrode coils 237 may radiate aradiofrequency signal directly into targeted tissue of the pulmonaryvein 214. In other embodiments, the electrode coil 237 may conduct adirect current into the target tissue to ablate (commonly referred to asirreversible electroporation). In yet further embodiments, the electrodecoil may have one or more expansion chambers distributed about the coil,to which supply and exhaust lumens deliver cryogenic fluid. Upon arrivalof cryogenic fluid (cryofluid) at the expansion chambers, the reductionin pressure within the expansion chamber causes a phase change fromliquid to gas which absorbs energy from the tissue in contact with theelectrode coils 237. In yet other embodiments, the electrode coils 237may deliver one or more of the following energies to the targetedtissue: laser, chemical, high-intensity focused ultrasound, amongothers.

Various balloon catheter implementations are envisioned including aballoon for ablating an antrum of a pulmonary vein. In such anembodiment, electrode coil 237 may be positioned toward a distal end ofballoon 236. The position of the electrode coil 237 facilitates directcontact between the antrum and the electrode coil 237. Yet otherablation balloon implementations consistent with the present disclosureare directed to ablating a pulmonary vein ostium. In such an embodiment,the electrode coil 237 may encompass a central circumferential portionof the balloon 236. During delivery, the balloon is positioned within aPV so that the electrode coil contacts the ostium when the balloon isexpanded, thereby facilitating an ablation therapy of just the ostialtissue. In such an embodiment, tissue and/or the blood pool in contactwith the proximal and distal portions of the balloon do not receiveablative energy as the electrode coil 237 is electrically isolated fromthe ablation therapy by at least the balloon 236.

FIG. 3 shows an ablation balloon catheter 331 within a left atrium 312L.The ablation balloon catheter includes a balloon 336 with acircumferentially extending electrode coil 337 advancing through anantral portion of a pulmonary vein 314. As a distal end 338 of theablation balloon catheter 331 enters the pulmonary vein 314, mapping maybe conducted using mapping electrodes attached to the electrode coil 337and/or attached to the catheter shaft 334 at distal and proximal ends ofthe balloon 336. The mapping may facilitate proper location of theballoon 336 prior to conducting an ablation therapy.

The electrode coil 337 extends about the balloon 336, and includes anablation means, such as RF electrodes distributed about the electrodecoil. It has been discovered that positioning RF electrodes into directcontact with target tissue for an ablation therapy facilitates preciseenergy transfer into the target tissue, while minimizing energy transferto non-target tissue and a blood pool surrounding portions of theballoon. In various embodiments of the present disclosure, the electrodecoil 337 may be coupled to an interior or exterior surface of theballoon, integral to the external surface of the balloon (e.g., fusedtogether), or entirely free-standing from the balloon. In yet furthermore specific embodiments, the electrode coil is free-standing relativeto the balloon and may be adjustable via a pull wire or other adjustmentmechanism to vary the location of the electrode coil to customize theablation for a given pulmonary vein topography, or to facilitatemultiple ablation locations with a single catheter. Such an embodimentfacilitates, for example, subsequent ablation therapies at antral andostial portions of the pulmonary vein. Moreover, one or more electrodecoils may extend around the balloon and take various shapes, as may bedesirable for a given application.

After an ablation therapy at a pulmonary vein antrum is complete, forexample, the ablation balloon may be collapsed for removal from thecardiac muscle 310 via the introducer 330, or may be repositioned and/orreconfigured to conduct additional ablation therapies to other pulmonaryveins and/or to the ostia of target pulmonary vein 314. For example, theelectrode coil 337 may be reconfigured relative to the balloon 336 toconduct ablation therapy on the ostia of the target pulmonary vein 314by moving the electrode coil 337 proximal relative to the balloon 336.

FIG. 4 shows an ablation balloon catheter 431 with a balloon 436positioned in contact with an antral portion 416 of pulmonary vein 414.An electrode coil 437 circumferentially extends about the balloon 436,and is positioned between the balloon 436 and the antrum 416. In thepresent embodiment, the ablation balloon catheter 431 is positioned toconduct an ablation therapy of the antrum 416 of the target pulmonaryvein 414. The ablation therapy ablates a circumferential ring around theantrum 416 using RF electrodes distributed about the electrode coil 437.By directly contacting the target tissue with the RF electrodes, alarger percentage of power emitted by the RF coil may be received by thetarget tissue—thereby limiting the flow of RF energy to non-targettissue and the blood pool. The circumferential zone of ablationelectrically isolates the left atrium 412L from electrical impulsesproduced by arrhythmiatic foci opposite the ablation.

As shown in FIG. 4, prior to inflation of ablation balloon 436,introducer sheath 430 delivers the ablation balloon catheter 431 intoleft atrium 412L. Catheter shaft 434 further aligns the balloon withtarget pulmonary vein 414. While therapy of antrum 416 may includeexpanding the balloon 436 before contacting the target tissue, therapyof pulmonary vein ostia 415 may require that distal tip 439 of theballoon catheter 431 be inserted into the pulmonary vein 414 beforeinflation.

In various embodiments of the present disclosure, ablation ballooncatheter 431, due at least in part to the direct contact betweenelectrode coil 437 and target tissue 416, facilitates efficient energytransfer between the RF coils within the electrode coil 437 and thetarget tissue. Due to the close correlation between the power deliveredto the RF coil by a signal generator and the actual power absorbed bythe target tissue, estimating an area of the resulting lesion at each ofthe RF coils based on the power delivered may be achieved. Due to thereliable estimation of lesion size, ablation therapy efficacy may begreatly improved, while reducing the likelihood that a follow-upablation therapy and/or the use of a single-point ablation catheter fortouch-up will be necessary.

In a typical ablation therapy, all pulmonary veins are treated. Theprocesses as described herein for right superior pulmonary vein 214 maybe replicated for each of the three other pulmonary veins, as shown inFIGS. 2-3.

FIG. 5 shows an isometric view of an ablation balloon catheter 500 witha distal portion 552 including an expanded balloon 536 and an electrodecoil 537 circumferentially extending around the balloon. The electrodecoil is coupled to the catheter shaft 534 at locations distal 552 andproximal the balloon 536 via lead wires 551A-B. Alternatively, theelectrode coil 537 may be coupled to the catheter shaft 534 by externalsupport structures with lead wires extending within a lumen or along anexterior surface, or via flexible electrical circuits that areelectrically coupled to the electrode coil 537 and to ablationcontroller circuitry at a proximal end of the catheter shaft 534. Theexpanded balloon 536 facilitates contouring of the electrode coil 537 toa length and circumference of a pulmonary vein. The electrode coil 537may include one or more RF emitters (e.g., an RF coil) distributed aboutthe electrode coil 537, which in response to a driving signal radiatesRF energy into tissue in contact with the electrode coil, therebyablating the tissue. The electrode coil 537 may be fitted into a concavefeature within an exterior surface of the balloon 536, facilitatingconstant contact between the balloon 536 and electrode coil 537 with alength and circumference of a pulmonary vein. While the direct contactbetween the electrode coil and tissue helps to facilitate efficient heattransfer to the tissue, the concave feature of the balloon 536 about theelectrode coil 537 insulates non-target tissue of the pulmonary veinfrom the emitted RF energy. In some embodiments, it may be desirable forthe balloon material and/or fluid within the balloon to be electricallyinsulative. Such an ablation balloon reduces ablation therapy times dueto the improved energy delivery to the target tissue, or may produceenhanced zones of ablation while maintaining therapy times.

Once ablation therapy is complete, balloon 536 may be collapsed, whichwill simultaneously collapse electrode coil 537, and ablation ballooncatheter 534 may be retracted back into introducer 330 (see, e.g., FIG.3). An electrophysiology catheter, or electrodes proximal and distal tothe ablation balloon 536 (for example), may be used to verify theefficacy of the therapy prior to removal of the ablation ballooncatheter 531.

In various embodiments of the present disclosure, electrode coil 537 mayalso include diagnostic and/or mapping electrodes. These electrodes maybe used before, during, and after the ablation therapy. For example,prior to the ablation therapy, the diagnostic electrodes may be used todetermine optimal positioning of the balloon to increase electricalisolation of the target pulmonary vein from the left atrium. During theablation therapy, the diagnostic electrodes may be used to track theablation efficacy. Specifically, the sensed data from the diagnosticelectrodes may be used to determine when sufficient isolation betweenthe pulmonary vein and the left atrium has been accomplished. Similarly,after completion of an ablation therapy, the diagnostic electrodes maybe used to determine the efficacy of the ablation therapy (including,e.g., ablation lesion characteristics such as depth and surface area, aswell as resistance to electrical stimulus), and whether additionaltherapy applications may be required.

Medical-device type balloons have been developed for a variety ofdifferent applications and take a number of different forms. Aspects ofthe present disclosure may utilize balloons of various types andmechanical construction. The balloons may be either self-erecting (e.g.,structurally biased toward a deployed configuration) or mechanicallyerected (e.g., via pull wire, or introduction of a fluid within theballoon). In one example embodiment, a lumen extending through a lengthof a shaft 534 of the ablation balloon catheter 500 may inject a fluidinto the ablation balloon which exerts a radial force on the ablationballoon—thereby expanding the balloon into a deployed configuration.While various embodiments of the present disclosure have been directedto the treatment of atrial fibrillation within pulmonary veins of ahuman heart, aspects of the present disclosure are not to be construedso narrowly, but may instead be applied to various types of tissue, andorgans within a human body.

FIG. 6 is an isometric side view of a deployed ablation balloon cathetersystem 600 with an ablation balloon catheter 631 and anelectrophysiology loop catheter 661 extending through a distal end of acentral lumen 652 of the ablation balloon catheter, consistent withvarious aspects of the present disclosure. Balloon 636 is coupled to adistal end of a catheter shaft 634 of the ablation balloon catheter 631.The central lumen 652 extends from a proximal to a distal end ofcatheter shaft 634, and facilitates the use of electrophysiologicalelectrodes on the electrophysiology loop catheter 661 to retrieveelectrophysiological data related to tissue distal the balloon 636. Insome applications, electrophysiology catheters may be positioned oneither side of the balloon 636 and facilitate collection ofelectrophysiological characteristics of the pulmonary vein to establishinformation including the efficacy of an ablation therapy. In onespecific embodiment, the electrophysiology loop catheter 661 may be usedas a reference while diagnostic electrodes on the electrode coil 637provide data indicative of the electrical signals received by the leftatrium of the heart, for example. Such a configuration is particularlyuseful after an ablation therapy to determine the efficacy of the lesionto block electrical signals from the pulmonary vein.

As shown in FIG. 6, two half-circle electrode coils 637circumferentially extend about an outer diameter of balloon 636. Theelectrode coils 637 are positioned longitudinally along the balloon 636,where the balloon is to contact target tissue for an ablation therapy(e.g., a pulmonary vein ostia or antrum). The electrode coils 637 may bemechanically coupled to the balloon 636 or freely floats above a surfaceof the balloon and maintained at a relative longitudinal dimension bylead wires 651A-D (or alternatively, flexible electrical circuits). Thelead wires 651A-D electrically couple the RF electrodes, and anyadditional electronic hardware on or within the electrode coils 637(e.g., diagnostic electrodes, thermocouples, pressure sensors, 3-Dmapping electrodes, etc.), to control circuitry at a proximal end of theablation catheter 631. In the present embodiment, lead wires 651A-Bextend distally along a surface of the balloon 636 from a proximal endof the balloon to the electrode coils 637, while lead wires 651C-Dextend distally from the electrode coils 637 to a distal end of theballoon 636. In various embodiments, it may be desirable for the leadwires to exhibit some stiffness to maintain a longitudinal position ofthe electrode coils 637 while the balloon 636 maintains thecircumferential profile of the electrode coils. When RF electrodesdistributed along the electrode coils 637 are operated, the tissue incontact with the RF electrodes are ablated to create lesions whichresist the conductive transfer of electrical signals between thepulmonary vein and the left atrium. As the electrode coils 637 almostcompletely circumnavigate the balloon 636, with the appropriatecombination of RF electrode distribution, and ablation therapy time andpower, the ablation lesion may essentially form a contiguous,transmural, circumferential lesion. Where the ablation lesion gap at thejuncture between the electrode coils 637 facilitates excessiveelectrical signal injection into the left atrium, RF coils adjacent thejuncture may be driven with more power than the interior RF coils toincrease the ablation lesion area near the juncture, thereby bridgingany lesion gap. In other embodiments, the electrode coils 637 maycircumferentially extend around the balloon 636 at least one completerotation.

In acute atrial fibrillation cases, it may be desirable to greatlyincrease the amount of lesioned tissue in a pulmonary vein to maximizethe electrical insulation between the pulmonary vein and the heart. Insuch embodiments, the ablation balloon catheter 631 may includemultiple, longitudinally offset electrode coils 637 that formcomplimentary circumferentially extending lesions in the pulmonary vein.These lesions, in conjunction with the healthy tissue between the lesionrings, greatly reduce the symptoms of, or cure all together, a patient'satrial fibrillation. The redundancy of two or more distally offset,circumferential lesions in the pulmonary vein help to mitigate theoccurrence of ineffective ablation therapy. Reasons that an ablationballoon catheter may fail to create a contiguous transmuralcircumferential lesion include insufficient pressure, lack of contactaltogether due to irregular pulmonary vein topography, and inflexibilityof the ablation balloon catheter 631. Spiraling electrode coilconfigurations may also provide enhanced electrical isolation betweenthe pulmonary vein and left atrium. While a spiraling lesion may stillallow an undisturbed, electrically conductive path between the pulmonaryvein and left atrium, that path is considerably extended. As a result,most electrical signal traffic to the heart will be isolated, and thesignal that does successfully traverse through the spiraled lesion willhave a reduced signal strength due to the imperfect conductivity of thePV tissue.

To facilitate transport of a balloon 636 of an ablation balloon catheter631 through an introducer and into position with a pulmonary vein, theballoon 636 is transported in a collapsed configuration. Prior to anablation therapy, the balloon 636 may be inflated using a fluid that isdelivered to the balloon 636 via a lumen extending a length of cathetershaft 634. The introduction of the fluid within the balloon 636 exerts aradial force that inflates the balloon 631. The radial force of theexpanding balloon 636 extends an electrode coil 637 encompassing theballoon 631 to a deployed configuration. When positioned in contact witha pulmonary vein ostia, for example, the radial force exerted upon theelectrode coil 637 by the balloon 636 facilitates consistentelectrode-tissue contact. When an ablation therapy is complete, theballoon 636 may be deflated by drawing fluid out of the balloon 636. Inyet other embodiments, the balloon 636 and/or the electrode coil 637 mayinclude a biased/deformable structure that may be deformed for deliveryand removal of the ablation balloon catheter 631 via an introducer. Thestructural bias of the balloon 636 and/or the electrode coil 637 furtherfacilitating expansion of the balloon 636 upon exiting the introducerand/or upon activation of a control wire. Such an embodiment may reducethe complexity of the ablation balloon catheter system 600 byeliminating the need for fluid flow through lumens within the cathetershaft to enact inflation and deflation of the balloon 636.

FIG. 7 is an isometric side view of a deployed balloon catheter 700 withtwo electrode coils 737. Each of the electrode coils 737 extendapproximately half way around a circumference of balloon 736. Theelectrode coils 737 are coupled at proximal and distal ends of theballoon 736 via lead wires 751 _(A-B). To help prevent electrode coilspread (which may prevent the electrode coils fitting snugly around theballoon 736 when deployed), an anchor tube 780 may extend over a portionof both lead wires 751 _(A-B). Distal lead wires may similarly utilizean anchor tube to prevent electrode coil spread. In various embodimentsof the present disclosure, the electrode coils 737 may include not onlyelectrodes for ablating tissue in contact with the electrode coils, butmay also include multi-mapping electrode(s) 771 _(A-D) (for conductingelectrophysiology mapping, for example), and magnetic sensor(s) 772 _(B)(for localization of the balloon 736). The electrode coil 737 mayinclude one or more of each of the multi-mapping electrodes 771 _(A-D)and the magnetic sensor 772 _(B).

During an ablation therapy, electrodes within the electrode coils 737transfer energy between the electrode coils 737 and tissue in contacttherewith. The ablation therapy may also inadvertently transfer someenergy to the blood pool surrounding the electrode coils 737, which maycause blood coagulation on and around the electrode coils, as well asblood charring on the electrode coils themselves. To minimize bloodcoagulation and charring, the fluid used to inflate balloon 736 may beirrigant fluid, and is evacuated from the balloon via irrigant ports 781_(A-N) that extend around a circumference of the balloon in proximity tothe electrode coils 737. The flow of irrigant fluid in proximity to theelectrode coils 737, during an ablation therapy, mitigates bloodcoagulation and charring on and around the electrode coils.

To further facilitate localization of a balloon catheter 700, a distalportion of catheter shaft 734 may include a magnetic sensor 772 _(A),which may be utilized in conjunction with magnetic sensor 772 _(B), tofacilitate precise localization of the balloon catheter 700. Byutilizing both of the magnetic sensors 772 _(A-B), orientation of theballoon catheter may also be determined. In yet further embodiments, adistal portion of catheter shaft 734 may also include a contact forcesensor assembly 773 which may determine a force exerted between balloon736/electrode coils 737 and tissue (e.g., an antral portion of apulmonary vein). In some specific embodiments, the contact force sensorassembly 773 may not only determine a force but also a vector of theforce exerted on the balloon. Accordingly, a clinician may be able todetermine when the electrode coils 737 are making consistent contactwith a circumferential portion of a pulmonary vein, for example. In someapplications, a force vector exerted along a longitudinal axis of theballoon catheter 700 may be indicative of consistent circumferentialcontact, whereas an off-axis force vector may be indicative ofinconsistent contact with the pulmonary vein and therefore may result inan inconsistent ablation lesion. An inconsistent ablation lesion maynegatively impact the efficacy of the ablation therapy.

FIG. 8A is an isometric side view of a deployed balloon catheter 800including a single electrode coil 837 that helically wraps around acircumferential portion of balloon 836. The electrode coil 837 mayinclude one or more multi-mapping electrodes 871 _(A-D) and magneticsensors 872 _(B) distributed along a length of the electrode coil. Tofurther facilitate localization of a balloon catheter 800, a distalportion of catheter shaft 834 may include a magnetic sensor 872 _(A),which may be utilized in conjunction with magnetic sensor 872 _(B) tofacilitate precise localization of the balloon catheter 700. Byutilizing both of the magnetic sensors 872 _(A-B), orientation data ofthe balloon catheter may also be determined. In yet further embodiments,a distal portion of catheter shaft 834 may also include a contact forcesensor assembly 873 which may determine a force exerted between balloon836/electrode coil 837 and tissue.

FIG. 8B is a profile view of a portion of a balloon catheter 800including a balloon 831 with an electrode coil 837 extendingcircumferentially around the balloon. As shown in FIG. 8B, the electrodecoil 837 is electrically coupled to lead wires 851 _(A-B) (one extendingdistally and the other proximally relative to the electrode coils). Thelead wires 851 _(A-B) may also structurally support the electrode coil837 and facilitate longitudinal positioning of the electrode coilrelative to balloon 831. Alternatively, the electrode coil 837 may becoupled to the catheter shaft by external support structures with leadwires extending within a lumen or along an exterior surface, or viaflexible electrical circuits that are electrically coupled to theelectrode coil 837 and to ablation controller circuitry at a proximalend of the catheter shaft. The expanded balloon 831 facilitatescontouring of the electrode coil 837 to a length and circumference of apulmonary vein. The electrode coil 837 may include one or more RFemitters (e.g., an RF coil) distributed about the electrode coil 837,which in response to a driving signal radiates RF energy into tissue incontact with the electrode coil, thereby ablating the tissue. As shownin FIG. 8A, the electrode coil 837 is fitted into a concave feature 870within an exterior surface of the balloon 831, facilitating constantcontact between the balloon 831/electrode coil 837 with a length andcircumference of a pulmonary vein, for example.

FIG. 8C is a cross-sectional side view of various electrode coilprofiles 837 _(A-D), consistent with various aspects of the presentdisclosure. Electrode coil profile 837 _(A) is a semi-circle, electrodecoil profile 837 _(B) is circular, electrode coil profile 837 _(C) isoval, and electrode coil profile 837 _(D) is generally rectangular withrounded corners. Various other electrode coil profiles are readilyenvisioned.

FIG. 9 is a profile view of an un-deployed balloon catheter 900,consistent with various aspects of the present disclosure. In FIG. 9,balloon 936 is un-deployed, facilitating electrode coils 937 to collapseto a rest state (e.g., utilizing shape-memory materials). In someembodiments, guidewires may extend through at least a portion of anchortube 980 and/or lead wires 951 _(A-B) to facilitate collapsing theelectrode coils 937. The deploying of the balloon 936 radially expandsthe electrode coils 937 about a circumference of the balloon.

Various balloon catheters consistent with the present disclosure includean electrode coil surrounding a balloon at the distal end of thecatheter. The electrode coil may be integrated with the balloon itself,or independent therefrom. In some embodiments, the balloon and theelectrode coil may be deployed (after delivery to a target tissue site)by introducing a fluid into a chamber within the balloon. In otherembodiments (or in conjunction with the previous embodiment), theelectrode coil may be integral to the balloon and have a structural biasthat assists expansion of the balloon upon exiting an introducer, forexample. When the balloon is expanded into contact with tissue, the RFelectrodes, temperature sensors, and diagnostic mapping electrodes onthe electrode coil are sandwiched between the balloon and the tissue.Electrical traces or lead wires extending from the RF electrodes,temperature sensors, and diagnostic mapping electrodes may be integratedwithin the electrode coil (or an external support structure thatmechanically supports the electrodes and sensors), or may extend alongone or more surfaces of the electrode coil and/or external supportstructure, and then through a lumen within a catheter shaft to a handle.Various embodiments may utilize flexible circuitry to electricallycouple the electrodes to lead wires within the catheter shaft and tofacilitate the inflation and deflation of the balloon.

In electrode coil embodiments utilizing flex circuitry, the flexcircuitry may include RF electrodes, diagnostic electrodes, andthermocouples that are electrically coupled to controller circuitry(e.g., an ablation subsystem, and an electrophysiology mapping system).The flexible electronic circuit may be mounted directly to the balloon,or to an external structure that at least partially encompasses theballoon. In other embodiments, the flex circuit may extend through alength of the catheter shaft, eliminating the need for a junctionbetween the flex circuit and lead wires within the catheter shaft.

Diagnostic electrodes on the electrode coils (and/or on the externalstructure that includes the electrode coils) may be utilized to measureelectrical potentials across ablated tissue. Where the electrode coilsinclude temperature sensors, the sensed temperature at theelectrode-tissue interface may be used to monitor tissue heating and tocontrol ablation therapy power. By focusing generated energy on targetedtissue and limiting the transfer of energy to the blood pool andnon-target tissue by positioning the electrode coils in contact withtarget issue, power required for ablation may be greatly reduced.

Flexible electrode coils, as disclosed in the various embodiments of thepresent disclosure, may conform to various shapes. To allow for suchflexibility, the electrode coils may be laser cut (or otherwise formed,modified, and/or machined) to control the shape of the electrode coilwhen the balloon is inflated (e.g., the electrode coil is placed understress). Upon deflation of the balloon, the electrode coil may return toa biased shape/size (e.g., FIG. 9). In such embodiments, once returnedto a biased shape/size, the balloon catheter may be withdrawn throughthe introducer. Various flexible electrode coils are disclosed in U.S.Patent publication 2010/0286684, which is hereby incorporated byreference as though fully set forth herein. Structures for variousmultiple flexible electrodes are further disclosed in U.S. Patentpublication 2013/0085479, which is hereby incorporated by reference asthough fully set forth herein. For example, the embodiment disclosed inFIG. 5 of U.S. Patent publication 2013/0085479 may be readily adapted inview of the present disclosure. Such a combination may further utilizeone or more additional electrodes for mapping and pacing between RFablating electrodes. Extended irrigation lumen(s) with variable holes tofacilitate delivery of fluid equally along the length of the ablating RFelectrodes may also be utilized. In various embodiments, multipleflexible electrode segments may be separated by less flexible, andnon-conductive, intermediate segments, as disclosed in U.S. Patentpublication 2013/0085479.

In various embodiments of the present disclosure, the flexible electrodecoils may take various shapes, orientations, and patterns about theballoon. For example, circular, elliptical, “D” shape, among othershapes that may facilitate improved electrode-tissue contact. Someembodiments may include a plurality of flexible electrode coils thatform multiple loops, and when activated create multiple contiguoustransmural circumferential lesions. This type of redundant electrodecoil configuration may greatly reduce the probability of incompleteelectrical signal blockage across the multiple lesions. In manyembodiments, an external structure may support the electrode coils, aswell as irrigant lumens and ports, and mapping electrodes interspersedbetween the RF electrodes.

Various embodiments may include ring electrodes at proximal and distalends of the ablation balloon to facilitate localization of the ablationballoon catheter within a patient (e.g., magnetic and impedance-based3-D mapping). A junction between the catheter shaft and the balloon mayalso include a contact force sensor for determining a contact forcebetween the electrode coils and tissue during an ablation therapy.

While the various figures of the present disclosure are generallydirected toward RF ablation techniques, such embodiments may be readilyadapted to facilitate various known ablation technologies includingultrasound, cryoablation, among others. In cryoablation implementations,an external structure surrounding the balloon may include cryofluidsupply lumen(s) that deliver a cryogenic fluid from a cryofluid supplyat a distal end of a catheter shaft to one or more expansion chambersabout the balloon. When the balloon is inflated, each of the expansionchambers within the external structure are placed into substantiallyequal contact with the PV tissue surrounding the balloon. Accordingly,upon introduction of cryofluid to the expansion chambers, the rapidexpansion of the cryogenic fluid into a gas phase absorbs a large amountof energy—thereby drawing energy out of the contacting tissue to achieveablation.

In one specific balloon catheter embodiment for cryogenic ablation, anexternal structure, surrounding a balloon, may include one or morelumens that deliver cryogenic fluid to one or more expansion chambersdistributed along a length of the external structure. This embodiment isreadily adaptable for two or more external structures surrounding all ora portion of a balloon. Cryogenic fluid is delivered, via the one ormore lumens within the one or more external structures, to the one ormore expansion chambers—which induces cooling of electrodes in proximityto the cooling chamber. Where the electrodes are in contact with tissue,the tissue will be ablated resulting in lesioned tissue. In morespecific embodiments, temperature sensors may be placed on or near theelectrodes to monitor the cooling of the electrodes and also tofacilitate control system feedback loops which may increase or decreasecryogenic fluid flow through the lumens and into the one or more coolingchambers based on a desired ablation temperature.

Embodiments of the present disclosure may utilize irrigant fluid toinflate a balloon and thereby extend RF electrodes on an electrode coilinto contact with PV tissue. In such embodiments, the balloon mayinclude irrigant ports that facilitate irrigation in proximity to theelectrode coil(s). Various irrigant ports (also referred to as weepingholes) are disclosed in U.S. Pat. No. 6,251,109, which is herebyincorporated by reference as though fully set forth herein. Moreover,the balloon profile may include one or more concave features tofacilitate positioning of the electrode coils about the balloon whilelimiting the longitudinal motion of the electrode coils relative to theballoon. The irrigant ports facilitate fluid flow about the interfacebetween the electrode coil and the balloon to limit blood charring onthe electrode coil and blood coagulation.

External structures that contain RF electrodes (or the electrode coilsthemselves) may take a variety of cross-sectional shapes includinground, elliptical, half-circular, and rectangular, for example.

Various embodiments of the electrode coils are directed to single-loopdesigns where a first external support structure extends over theballoon from a proximal end of the balloon to a position on the balloonwhere a target tissue will contact the balloon once the ablationcatheter is delivered. A single-loop electrode coil circumferentiallyextends from the distal end of the first external support structurearound the balloon and is coupled to a second external support structurethat extends longitudinally to a distal end of the ablation balloon. Inyet other embodiments, the second external support structure may insteadextend back to a proximal end of the balloon. The external supportstructure may be a hollow tube to facilitate lead wires necessary tooperate the RF coils, diagnostic electrodes, mapping electrodes, etc. Inyet other embodiments, the lead wires may be run external to theexternal support structures.

Some embodiments of electrode coils disclosed herein are directed todouble-loop designs. In such embodiments, two external supportstructures extend distally from a proximal end of the balloon interfacewith the catheter shaft to a position on the balloon where a targettissue will contact the balloon. Electrode coils coupled to each of theexternal support structures circumferentially extend around the balloonin opposite directions. Each of the electrode coils extend approximately180 degrees around the circumference of the balloon, where the electrodecoils are coupled to another set of external support structures thatextend to a distal end of the ablation balloon. In yet otherembodiments, the other set of external support structures may insteadextend back to a proximal end of the balloon. It may further beadvantageous to combine or otherwise couple the paired external supportstructure to improve structural rigidity.

Aspects of the present disclosure are directed to an ablation balloonwhich utilizes direct current applied across target pulmonary veintissue to cause ablation (also referred to as irreversibleelectroporation). In such embodiments, the electrode coil includesirreversible electroporation (IRE) electrodes distributed about acircumference of the balloon (similar to the RF embodiments disclosedabove). An electroporation pulse generated by a source may transmit anIRE pulse through lead wires extending a length of the catheter shaft tothe IRE electrodes which are in contact with tissue—thereby ablating thetissue.

Based upon the above discussion and illustrations, those skilled in theart will readily recognize that various modifications and changes may bemade to the various embodiments without strictly following the exemplaryembodiments and applications illustrated and described herein. Suchmodifications do not depart from the true spirit and scope of variousaspects of the disclosure, including aspects set forth in the claims.

Although several embodiments have been described above with a certaindegree of particularity to facilitate an understanding of at least someways in which the disclosure may be practiced, those skilled in the artcould make numerous alterations to the disclosed embodiments withoutdeparting from the scope of the present disclosure and the appendedclaims. It is intended that all matter contained in the abovedescription or shown in the accompanying drawings shall be interpretedas illustrative only and not limiting. Accordingly, the examples andembodiments herein should not be construed as limiting the scope of thedisclosure. Changes in detail or structure may be made without departingfrom the present teachings. The foregoing description and followingclaims are intended to cover all such modifications and variations.

Various embodiments are described herein of various apparatuses,systems, and methods. Numerous specific details are set forth to providea thorough understanding of the overall structure, function,manufacture, and use of the embodiments as described in thespecification and illustrated in the accompanying drawings. It will beunderstood by those skilled in the art, however, that the embodimentsmay be practiced without such specific details. In other instances,well-known operations, components, and elements may not have beendescribed in detail so as not to obscure the embodiments described inthe specification. Those of ordinary skill in the art will understandthat the embodiments described and illustrated herein are non-limitingexamples, and thus it can be appreciated that the specific structuraland functional details disclosed herein may be representative and do notnecessarily limit the scope of the embodiments, the scope of which isdefined solely by the appended claims.

The terms “including,” “comprising” and variations thereof, as used inthis disclosure, mean “including, but not limited to,” unless expressspecified otherwise. The terms “a,” “an,” and “the,” as used in thisdisclosure, means “one or more,” unless expressly specified otherwise.

Reference throughout the specification to “various embodiments,” “someembodiments,” “one embodiment,” “an embodiment,” or the like, means thata particular feature, structure, or characteristic described inconnection with the embodiment is included in at least one embodiment.Thus, appearances of the phrases “in various embodiments,” “in someembodiments,” “in one embodiment,” “in an embodiment,” or the like, inplaces throughout the specification are not necessarily all referring tothe same embodiment. Furthermore, the particular features, structures,or characteristics may be combined in any suitable manner in one or moreembodiments. Thus, the particular features, structures, orcharacteristics illustrated or described in connection with oneembodiment may be combined, in whole or in part, with the features,structures, or characteristics of one or more other embodiments withoutlimitation.

Although process steps, method steps, algorithms, or the like, may bedescribed in a sequential order, such processes, methods, and algorithmsmay be configured to work in alternative orders. In other words, anysequence or order of steps that may be described does not necessarilyindicate a requirement that the steps be performed in that order. Thesteps of the processes, methods, and algorithms described herein may beperformed in any order practical. Further, some steps may be performedsimultaneously.

When a single device or article is described herein, it will be readilyapparent that more than one device or article may be used in place of asingle device or article. Similarly, where more than one device orarticle is described herein, it will be readily apparent that a singledevice or article may be used in place of the more than one device orarticle. The functionality or the features of a device may bealternatively embodied by one or more other devices which are notexplicitly described as having such functionality or features.

It will be appreciated that the terms “proximal” and “distal” may beused throughout the specification with reference to a clinicianmanipulating one end of an instrument used to treat a patient. The term“proximal” refers to the portion of the instrument closest to theclinician and the term “distal” refers to the portion located furthestfrom the clinician. However, surgical instruments may be used in manyorientations and positions, and these terms are not intended to belimiting and absolute. All other directional or spatial references(e.g., upper, lower, upward, downward, left, right, leftward, rightward,top, bottom, above, below, vertical, horizontal, clockwise, andcounterclockwise) are only used for identification purposes to aid thereader's understanding of the present disclosure, and do not createlimitations, particularly as to the position, orientation, or use of thedisclosure. Joinder references (e.g., attached, coupled, connected, andthe like) are to be construed broadly and may include intermediatemembers between a connection of elements and relative movement betweenelements. As such, joinder references do not necessarily infer that twoelements are directly connected and in fixed relation to each other.

Any patent, publication, or other disclosure material, in whole or inpart, that is said to be incorporated by reference herein isincorporated herein only to the extent that the incorporated materialsdoes not conflict with existing definitions, statements, or otherdisclosure material set forth in this disclosure. As such, and to theextent necessary, the disclosure as explicitly set forth hereinsupersedes any conflicting material incorporated herein by reference.Any material, or portion thereof, that is said to be incorporated byreference herein, but which conflicts with existing definitions,statements, or other disclosure material set forth herein will only beincorporated to the extent that no conflict arises between thatincorporated material and the existing disclosure material.

What is claimed is:
 1. An ablation balloon catheter apparatuscomprising: a catheter shaft including proximal and distal ends; aballoon including proximal and distal ends, the proximal end of theballoon coupled to a distal end of the catheter shaft; and an electrodecoil configured to transfer energy between the electrode coil and tissuein contact with the electrode coil, wherein the electrode coil includesa first portion and a second portion, the first portion of the electrodecoil extends circumferentially around a first half of the balloon, andthe second portion of the electrode coil extends circumferentiallyaround a second half of the balloon.
 2. The apparatus of claim 1,wherein the balloon is configured to engage a pulmonary vein of acardiac muscle along a length and circumference of the balloon, therebyplacing the electrode coil into contact with a circumferential portionof the pulmonary vein, and the electrode coil is further configured todeliver a tissue ablation therapy to the circumferential portion of thepulmonary vein in contact with the electrode coil.
 3. The apparatus ofclaim 2, wherein the balloon is further configured to insulate thepulmonary vein tissue engaged by the balloon from the tissue ablationtherapy, the first portion of the electrode coil wraps around theballoon in a first direction, and the second portion of the electrodecoil wraps around the balloon in a second direction opposite the firstdirection.
 4. The apparatus of claim 1, wherein the electrode coil ispositioned at a central portion of the balloon relative to alongitudinal axis of the apparatus, and the electrode coil is furtherconfigured to deliver a tissue ablation therapy along a circumference ofa pulmonary vein ostium in contact with the electrode coil.
 5. Theapparatus of claim 1, wherein the electrode coil is situated at a distalend of the balloon relative to a longitudinal axis of the apparatus, andthe electrode coil is configured and arranged to deliver a tissueablation therapy along a circumference of a pulmonary vein antrum incontact with the electrode coil.
 6. The apparatus of claim 1, furtherincluding a signal generator configured to generate a signal; andwherein the electrode coil includes a plurality of radio frequencyelectrodes, the radio frequency electrodes electrically coupled to thesignal generator, and the radio frequency electrodes are configured toengage a first length and circumference of a pulmonary vein, and emitradio frequency waves, in response to the generated signal, that ablatesthe pulmonary vein tissue in contact with the radio frequencyelectrodes.
 7. The apparatus of claim 6, wherein the balloon isconfigured to engage a second length and circumference of the pulmonaryvein adjacent to the first length and circumference of the pulmonaryvein, and shield the pulmonary vein tissue in contact with the balloonfrom the radio frequency waves transmitted by the radio frequencyelectrodes.
 8. The apparatus of claim 1, wherein each of the first andsecond portions of the electrode coil is coupled to the catheter shaftdistal the balloon, and proximal the balloon.
 9. The apparatus of claim1, wherein the electrode coil includes one or more of the following:diagnostic electrodes, thermocouples, and magnetic or impedance-basedmapping sensors.
 10. The apparatus of claim 1, wherein the electrodecoil includes diagnostic electrodes configured to detectelectrophysiological characteristics of tissue in contact with thediagnostic electrodes.
 11. The apparatus of claim 1, wherein energy istransferred between the electrode coil and tissue in contact with theelectrode coil via irreversible electroporation.
 12. The apparatus ofclaim 1, wherein the electrode coil is configured to receive a cryogenicfluid that absorbs heat from tissue in contact with the electrode coil,and the balloon is further configured to insulate the cryogenic fluidfrom heat associated with a blood pool and tissue in contact with theballoon.
 13. A system for treating atrial fibrillation, the systemcomprising: an introducer including a lumen extending through a lengthof the introducer; a balloon delivery catheter configured to extendthrough the lumen of the introducer; a balloon coupled to a distal endof the balloon delivery catheter; and an electrode coil configured toengage with a tissue wall of a pulmonary vein, and deliver an ablationtherapy along the tissue wall of the pulmonary vein engaged by theelectrode coil; wherein the electrode coil includes a first portion anda second portion, the first portion of the electrode coil extendscircumferentially around a first half of the balloon in a firstdirection, and the second portion of the electrode coil extendscircumferentially around a second half of the balloon in a seconddirection opposite the first direction.
 14. The system of claim 13,wherein the balloon is configured to engage with a length andcircumference of the pulmonary vein adjacent to the tissue wall engagedwith the electrode coil, and insulate the length and circumference ofthe pulmonary vein engaged by the balloon from the ablation therapy. 15.The system of claim 13, further including a signal generator, andwherein the electrode coil includes a plurality of radio frequencycoils, the plurality of radio frequency coils electrically coupled tothe signal generator via lead wires extending through a length of theballoon delivery catheter, and configured to receive a generated signalfrom the signal generator and emit a radio frequency signal.
 16. Thesystem of claim 13, wherein the electrode coil is further configured toreceive a cryofluid that absorbs heat from the tissue wall of thepulmonary vein engaged with the electrode coil; and the balloon isconfigured to insulate the cryofluid from heat within the tissue wall ofthe pulmonary vein in contact with the balloon.
 17. A balloon catheterfor pulmonary vein isolation comprising: a steerable balloon deliverycatheter shaft configured to deploy a balloon into a pulmonary vein; theballoon is coupled to a distal end of the steerable balloon deliverycatheter shaft, and configured to deploy from an undeployedconfiguration, and engage a tissue wall of the pulmonary vein; and atissue ablation means including first and second portions coupled to thedistal end of the catheter shaft and extending distally together along asurface of the balloon, wherein at a mid-point of the balloon, the firstportion extends circumferentially about the balloon in a first directionand the second portion extends circumferentially about the balloon in asecond direction opposite the first direction, and wherein the first andsecond portions meet at the opposite side of the balloon and extenddistally together along a surface of the balloon and are coupled to thedistal end of the balloon; wherein the tissue ablation means isconfigured to deliver an ablation therapy to the tissue wall of thepulmonary vein in contact with the tissue ablation means.
 18. Theballoon catheter of claim 17, wherein the tissue ablation means is oneor more of the following: cryoablation, irreversible electroporation,laser energy, radio frequency energy, microwave energy, chemicalreaction, and high-intensity focused ultrasound.
 19. The ballooncatheter of claim 17, wherein the tissue ablation means is positionednear a distal portion of the balloon, and is further configured toengage and to conduct an ablation therapy of an antral circumference ofthe pulmonary vein, the proximal portion of the balloon configured andarranged to insulate a blood pool and the pulmonary vein tissue incontact with a proximal portion of the balloon.
 20. The balloon catheterof claim 17, wherein the balloon is configured to mitigate the deliveryof the ablation therapy to the tissue wall of the pulmonary vein incontact with the balloon.